Literature DB >> 11326016

The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type.

V Ramachandran1, M A Hornitzky, K A Bettelheim, M J Walker, S P Djordjevic.   

Abstract

Shiga toxin 2 (Stx2) has been reported as the main Shiga toxin associated with human disease. In addition, the Stx2 toxin type can have a profound impact on the degree of tissue damage in animal models. We have characterized the stx(2) subtype of 168 Shiga toxin-producing Escherichia coli (STEC) isolates of which 146 were derived from ovine sources (principally feces and meat) and 22 were isolated from humans. The ovine STEC isolates were of serotypes that have been shown to occur commonly in the gastrointestinal tract of healthy sheep. The major stx(2) subtype in the ovine isolates was shown to be stx(2d-Ount) (119 of 146 [81.5%]) and was predominantly associated with serotypes O75:H(-)/H8/H40, O91:H(-), O123:H(-), O128:H2, and OR:H2. However, 17 of 18 (94.4%) ovine isolates of serotype O5:H(-) possessed a stx(2d-O111/OX3a) subtype. Furthermore, STEC isolates of serotypes commonly found in sheep and recovered from both clinical and nonclinical human infections also contained a stx(2d) (stx(2d-Ount/O111/OX3a)) subtype. These studies suggest that a specific stx(2) subtype(s) associates with serotype and may have important epidemiological implications for tracing sources of E. coli during outbreaks of STEC-associated diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326016      PMCID: PMC88051          DOI: 10.1128/JCM.39.5.1932-1937.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d.

Authors:  J F Kokai-Kun; A R Melton-Celsa; A D O'Brien
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

3.  Acute community-acquired diarrhea requiring hospital admission in Swiss children.

Authors:  B Essers; A P Burnens; F M Lanfranchini; S G Somaruga; R O von Vigier; U B Schaad; C Aebi; M G Bianchetti
Journal:  Clin Infect Dis       Date:  2000-07       Impact factor: 9.079

4.  Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples.

Authors:  Denis Piérard; Daniel Stevens; Leo Moriau; Hermy Lior; Sabine Lauwers
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

5.  A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.

Authors:  H Schmidt; J Scheef; S Morabito; A Caprioli; L H Wieler; H Karch
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

6.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Cloning and sequencing of two new Verotoxin 2 variant genes of Escherichia coli isolated from cases of human and bovine diarrhea.

Authors:  Z Lin; S Yamasaki; H Kurazono; M Ohmura; T Karasawa; T Inoue; S Sakamoto; T Suganami; T Takeoka; Y Taniguchi
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

8.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Detection and long-term existence of Shiga toxin (Stx)-producing Escherichia coli in sheep.

Authors:  H Asakura; S Makino; T Shirahata; T Tsukamoto; H Kurazono; T Ikeda; K Takeshi
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

10.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.

Authors:  A R Melton-Celsa; S C Darnell; A D O'Brien
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  23 in total

1.  Virulence properties and serotypes of Shiga toxin-producing Escherichia coli from healthy Australian cattle.

Authors:  Michael A Hornitzky; Barbara A Vanselow; Keith Walker; Karl A Bettelheim; Bruce Corney; Paul Gill; Graham Bailey; Steven P Djordjevic
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

2.  Nucleotide sequence-based multitarget identification.

Authors:  T Vinayagamoorthy; Kirk Mulatz; Roger Hodkinson
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Presence of activatable Shiga toxin genotype (stx(2d)) in Shiga toxigenic Escherichia coli from livestock sources.

Authors:  Kari S Gobius; Glen M Higgs; Patricia M Desmarchelier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity.

Authors:  Alejandra Krüger; Paula M A Lucchesi; Alberto E Parma
Journal:  Appl Environ Microbiol       Date:  2010-10-29       Impact factor: 4.792

5.  Virulence properties and serotypes of Shiga toxin-producing Escherichia coli from healthy Australian slaughter-age sheep.

Authors:  S P Djordjevic; M A Hornitzky; G Bailey; P Gill; B Vanselow; K Walker; K A Bettelheim
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.

Authors:  Abhineet S Sheoran; Susan Chapman-Bonofiglio; Barrett R Harvey; Jean Mukherjee; George Georgiou; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  stx1c Is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle.

Authors:  Kim N Brett; Vidiya Ramachandran; Michael A Hornitzky; Karl A Bettelheim; Mark J Walker; Steven P Djordjevic
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 8.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Serotypes and virulence gene profiles of shiga toxin-producing Escherichia coli strains isolated from feces of pasture-fed and lot-fed sheep.

Authors:  Steven P Djordjevic; Vidiya Ramachandran; Karl A Bettelheim; Barbara A Vanselow; Peter Holst; Graham Bailey; Michael A Hornitzky
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

10.  Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.

Authors:  Lothar Beutin; Gladys Krause; Sonja Zimmermann; Stefan Kaulfuss; Kerstin Gleier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.